| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A life immersed in science
|
Morgan, Jules
|
|
|
2 |
7 |
p. e392
|
artikel
|
| 2 |
Anakinra for patients with COVID-19
|
Martin-Silva, Nicolas
|
|
|
2 |
7 |
p. e382-e383
|
artikel
|
| 3 |
Anakinra for patients with COVID-19
|
Valette, Xavier
|
|
|
2 |
7 |
p. e382
|
artikel
|
| 4 |
Anakinra for patients with COVID-19
|
Maoujoud, Omar
|
|
|
2 |
7 |
p. e383
|
artikel
|
| 5 |
Anakinra for patients with COVID-19 – Authors' reply
|
Cavalli, Giulio
|
|
|
2 |
7 |
p. e383-e384
|
artikel
|
| 6 |
Anakinra for severe forms of COVID-19: a cohort study
|
Huet, Thomas
|
|
|
2 |
7 |
p. e393-e400
|
artikel
|
| 7 |
Anakinra in COVID-19: important considerations for clinical trials
|
King, Andrew
|
|
|
2 |
7 |
p. e379-e381
|
artikel
|
| 8 |
Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study
|
Wells, Philippa M
|
|
|
2 |
7 |
p. e418-e427
|
artikel
|
| 9 |
A strong voice for young people with arthritis
|
Morgan, Jules
|
|
|
2 |
7 |
p. e391
|
artikel
|
| 10 |
Checking up on checkpoint inhibitors
|
The Lancet Rheumatology,
|
|
|
2 |
7 |
p. e369
|
artikel
|
| 11 |
Coronavirus is the trigger, but the immune response is deadly
|
Cron, Randy Q
|
|
|
2 |
7 |
p. e370-e371
|
artikel
|
| 12 |
Correction to Lancet Rheumatol 2020; 2: e270–80
|
|
|
|
2 |
7 |
p. e388
|
artikel
|
| 13 |
Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
|
Teng, Jialin
|
|
|
2 |
7 |
p. e384-e385
|
artikel
|
| 14 |
Genetics, Prevotella, and the pathogenesis of rheumatoid arthritis
|
Stoll, Matthew L
|
|
|
2 |
7 |
p. e375-e376
|
artikel
|
| 15 |
Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic
|
Banerjee, Soumya
|
|
|
2 |
7 |
p. e385-e386
|
artikel
|
| 16 |
Hydroxychloroquine side-effects raise concerns for rheumatology patients
|
Owens, Brian
|
|
|
2 |
7 |
p. e390
|
artikel
|
| 17 |
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
|
McGonagle, Dennis
|
|
|
2 |
7 |
p. e437-e445
|
artikel
|
| 18 |
Improving the management of sciatica
|
Koes, Bart W
|
|
|
2 |
7 |
p. e372-e373
|
artikel
|
| 19 |
Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
|
Pain, Clare E
|
|
|
2 |
7 |
p. e376-e379
|
artikel
|
| 20 |
Oculomasticatory myorhythmia in Whipple's disease
|
Deriaz, Sophie
|
|
|
2 |
7 |
p. e446
|
artikel
|
| 21 |
Research in Brief
|
Thorley, Jennifer
|
|
|
2 |
7 |
p. e389
|
artikel
|
| 22 |
Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic
|
Marzo-Ortega, Helena
|
|
|
2 |
7 |
p. e386-e387
|
artikel
|
| 23 |
Stratified care versus usual care for management of patients presenting with sciatica in primary care (SCOPiC): a randomised controlled trial
|
Konstantinou, Kika
|
|
|
2 |
7 |
p. e401-e411
|
artikel
|
| 24 |
The immunology of COVID-19: is immune modulation an option for treatment?
|
Zhong, Jixin
|
|
|
2 |
7 |
p. e428-e436
|
artikel
|
| 25 |
The value of antinuclear antibody testing and retesting
|
Pisetsky, David S
|
|
|
2 |
7 |
p. e373-e374
|
artikel
|
| 26 |
Utility of repeated antinuclear antibody tests: a retrospective database study
|
Yeo, Ai Li
|
|
|
2 |
7 |
p. e412-e417
|
artikel
|
Tijdschrift beschrijving